These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 16037304

  • 1. Renoprotective and lipid-lowering effects of LR compounds, novel advanced glycation end product inhibitors, in streptozotocin-induced diabetic rats.
    Figarola JL, Scott S, Loera S, Xi B, Synold T, Rahbar S.
    Ann N Y Acad Sci; 2005 Jun; 1043():767-76. PubMed ID: 16037304
    [Abstract] [Full Text] [Related]

  • 2. Prevention of early renal disease, dyslipidaemia and lipid peroxidation in STZ-diabetic rats by LR-9 and LR-74, novel AGE inhibitors.
    Figarola JL, Scott S, Loera S, Xi B, Synold T, Weiss L, Rahbar S.
    Diabetes Metab Res Rev; 2005 Jun; 21(6):533-44. PubMed ID: 15818713
    [Abstract] [Full Text] [Related]

  • 3. Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.
    Degenhardt TP, Alderson NL, Arrington DD, Beattie RJ, Basgen JM, Steffes MW, Thorpe SR, Baynes JW.
    Kidney Int; 2002 Mar; 61(3):939-50. PubMed ID: 11849448
    [Abstract] [Full Text] [Related]

  • 4. Novel inhibitors of glycation and AGE formation.
    Rahbar S.
    Cell Biochem Biophys; 2007 Mar; 48(2-3):147-57. PubMed ID: 17709884
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Therapeutic effect of green tea extract on advanced glycation and cross-linking of collagen in the aorta of streptozotocin diabetic rats.
    Babu PV, Sabitha KE, Shyamaladevi CS.
    Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):351-7. PubMed ID: 16620300
    [Abstract] [Full Text] [Related]

  • 7. High-dose thiamine therapy counters dyslipidemia and advanced glycation of plasma protein in streptozotocin-induced diabetic rats.
    Karachalias N, Babaei-Jadidi R, Kupich C, Ahmed N, Thornalley PJ.
    Ann N Y Acad Sci; 2005 Jun; 1043():777-83. PubMed ID: 16037305
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
    Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY, Sourris KC, Penfold SA, Bach LA, Cooper ME, Forbes JM.
    Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
    [Abstract] [Full Text] [Related]

  • 12. Antihyperglycemic activity and inhibition of advanced glycation end product formation by Cuminum cyminum in streptozotocin induced diabetic rats.
    Jagtap AG, Patil PB.
    Food Chem Toxicol; 2010 Feb; 48(8-9):2030-6. PubMed ID: 20451573
    [Abstract] [Full Text] [Related]

  • 13. A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats.
    Bhatwadekar A, Glenn JV, Figarola JL, Scott S, Gardiner TA, Rahbar S, Stitt AW.
    Br J Ophthalmol; 2008 Apr; 92(4):545-7. PubMed ID: 18211931
    [Abstract] [Full Text] [Related]

  • 14. Renoprotective effects of a novel inhibitor of advanced glycation.
    Forbes JM, Soulis T, Thallas V, Panagiotopoulos S, Long DM, Vasan S, Wagle D, Jerums G, Cooper ME.
    Diabetologia; 2001 Jan; 44(1):108-14. PubMed ID: 11206401
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The protective effect of Salvia miltiorrhiza in an animal model of early experimentally induced diabetic nephropathy.
    Lee SH, Kim YS, Lee SJ, Lee BC.
    J Ethnopharmacol; 2011 Oct 11; 137(3):1409-14. PubMed ID: 21856399
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
    Nakamura S, Tachikawa T, Tobita K, Aoyama I, Takayama F, Enomoto A, Niwa T.
    Am J Kidney Dis; 2003 Mar 11; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
    [Abstract] [Full Text] [Related]

  • 20. Beneficial effects of Chinese prescription Kangen-karyu on diabetes associated with hyperlipidemia, advanced glycation endproducts, and oxidative stress in streptozotocin-induced diabetic rats.
    Kim HY, Okamoto T, Yokozawa T.
    J Ethnopharmacol; 2009 Jul 15; 124(2):263-9. PubMed ID: 19397970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.